Conbercept for Polypoidal Choroidal Vasculopathy（START Study）

NCT05229237 · clinicaltrials.gov ↗

COMPLETED

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Polypoidal Choroidal Vasculopathy
Conbercept

Interventions

DRUG: Conbercept

Sponsor

Peking Union Medical College Hospital